Misonidazole
Misonidazole is a chemical compound that has been studied for its potential medical applications, particularly in the field of oncology. It belongs to a class of compounds known as nitroimidazoles, which have shown promise in the treatment of certain types of cancer.
Chemical Structure[edit | edit source]
Misonidazole has the chemical formula C₆H₁₂N₄O₃ and a molecular weight of 176.18 g/mol. Its chemical structure consists of a nitroimidazole ring with a methyl group attached to the nitrogen atom.
Medical Uses[edit | edit source]
Misonidazole is primarily known for its radiosensitizing properties. When administered to cancer patients prior to radiation therapy, misonidazole can enhance the effectiveness of the treatment by making cancer cells more sensitive to radiation. This can lead to improved outcomes for patients undergoing radiotherapy for various types of cancer.
Mechanism of Action[edit | edit source]
The exact mechanism of action of misonidazole as a radiosensitizer is not fully understood. However, it is believed that misonidazole is selectively taken up by hypoxic (low-oxygen) cells within tumors. Once inside these cells, misonidazole undergoes a chemical reaction that generates toxic byproducts when exposed to radiation. This process helps to increase the effectiveness of radiation therapy specifically on the hypoxic regions of the tumor.
Side Effects[edit | edit source]
Like any medication, misonidazole can cause side effects in some patients. Common side effects may include nausea, vomiting, dizziness, and headache. In rare cases, more serious side effects such as allergic reactions or neurological symptoms may occur. Patients should be closely monitored during treatment with misonidazole to ensure their safety and well-being.
Research and Clinical Trials[edit | edit source]
Research on misonidazole and other nitroimidazoles is ongoing, with the aim of improving cancer treatment outcomes and reducing side effects for patients undergoing radiation therapy. Clinical trials are being conducted to evaluate the efficacy and safety of misonidazole in combination with other cancer treatments.
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
